New device aims to lower eye pressure during cataract surgery

NCT ID NCT06979752

Recruiting now Disease control Sponsor: Hôpital Privé de la Baie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called the Tran cannula, used during cataract surgery to clean away debris from the eye's drainage system in patients with pseudoexfoliative glaucoma. The goal is to see if it lowers eye pressure better than standard irrigation. Fifty-eight adults with both cataract and early-to-moderate glaucoma will be randomly assigned to receive either the Tran cannula or extra irrigation during surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tran cannula (a single-use irrigation device used during surgery)
What this could lead to: If it works, this could offer a safer, more effective way to lower eye pressure during cataract surgery for people with pseudoexfoliative glaucoma.
What could go wrong: This is a small, early-stage trial with only 58 participants. The device may not lower eye pressure better than standard irrigation, and surgical risks like infection or inflammation remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract exfoliation syndrome glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT GLAUCOMA, OPEN ANGLE, PSEUDO-EXFOLIATIVE

Contacts and locations

Locations

Clinique de la Côte d'Emeraude
NOT_YET_RECRUITING

St-Malo, 35400, France
Fondation Rothschild
RECRUITING

Paris, France
Hôpital Privé de la Baie
RECRUITING

Avranches, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.